Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Adult Langerhans Cell Histiocytosis"'
Autor:
Marcus Y. Chen, Edmond J. FitzGibbon, William A. Gahl, Skand Shekhar, Fady Hannah-Shmouni, Beth Solomon, Rahul Dave, Leora E. Comis, Juvianee Estrada-Veras, Kevin O'Brien, Bernadette R. Gochuico
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:1312-1318
Adult-onset histiocytoses (AOH), primarily Rosai-Dorfman disease (RDD), Erdheim-Chester Disease (ECD), and adult Langerhans cell histiocytosis (ALCH), are a group of related histiocytic neoplastic disorders featuring multisystemic manifestations. The
Publikováno v:
NMC Case Report Journal
Langerhans cell histiocytosis (LCH) is a disease characterized by the proliferation of Langerhans cells. Most cases of LCH occur in children, although it can be seen in adults as well. We encountered an adult case of LCH. A 44-year-old woman who was
Autor:
Aishwarya Ravindran, Ronald S. Go, Gordon Ruan, Gaurav Goyal, Robert Vassallo, Jason R. Young, Jithma P. Abeykoon, Caleb Scheckel, W. Oliver Tobin, Karen L. Rech, N. Nora Bennani, Jay H. Ryu, Antonious Z. Hazim, Mithun Vinod Shah, Matthew J. Koster
Publikováno v:
The Oncologist. 25:1001-1004
Langerhans cell histiocytosis (LCH) is a rare histiocytic neoplasm. To date, there is a lack of U.S. Food and Drug Administration–approved treatments in adult LCH to establish optimal first-line therapy. We conducted a retrospective, single-center
Autor:
Minghui Duan, Zhiyong Liang, Jian Sun, Xue-min Gao, Daobin Zhou, Ting Liu, Xinxin Cao, Jian Li, Lu Zhang, Jia Chen, Ai-lin Zhao, Huacong Cai, Hao Cai
Publikováno v:
American journal of hematologyREFERENCES. 97(2)
Adult Langerhans cell histiocytosis (LCH) remains poorly defined. We retrospectively studied 266 newly diagnosed LCH patients to understand the clinical presentation, treatment and prognosis of adult LCH. The median age at diagnosis was 32 years (ran
Autor:
Christopher Duarte-Celada, Smathorn Thakolwiboon, Walter R. Duarte-Celada, Mirla Avila, Luis Brandi
Publikováno v:
Proc (Bayl Univ Med Cent)
Langerhans cell histiocytosis (LCH), a disorder characterized by aberrant function and proliferation of mononuclear phagocytic cells called Langerhans cells, usually occurs in those
Publikováno v:
International Journal of Dermatology and Venerology, Vol 4, Iss 2, Pp 122-124 (2021)
Introduction:. Langerhans cell histiocytosis (LCH), the most common histiocytic disorder, characterized by the abnormal over production of histiocytes that tend to infiltrate single or multiple organ systems leading to significant tissue damage. Here
Publikováno v:
World Journal of Hematology. 8:1-8
Adult Langerhans cell histiocytosis and immunomodulatory drugs: Review and analysis of thirty-four case reports
Autor:
In Kyeong Kim, Kyoung Yul Lee
Publikováno v:
BMJ Case Reports
We report an extremely rare case of adult Langerhans cell histiocytosis (LCH) in a patient with papillary thyroid carcinoma (PTC) and Castleman disease (CD). A 46-year-old man visited our hospital with anaemia; systemic imaging showed an abdominal an
Publikováno v:
Journal of Medical Case Reports
Journal of Medical Case Reports, Vol 14, Iss 1, Pp 1-10 (2020)
Journal of Medical Case Reports, Vol 14, Iss 1, Pp 1-10 (2020)
Background Langerhans cell tumors are rare clonal disorders characterized by neoplastic proliferation of dendritic cells that can be further classified into the subtypes Langerhans cell histiocytosis and Langerhans cell sarcoma, which are rare neopla
Autor:
Jorge Esquiche León, Luciana Yamamoto Almeida, Evânio Vilela Silva, Heitor Albergoni Da Silveira, Fernando Chahud, Glauce L. Trevisan, Léa Assed Bezerra da Silva, Xiomara Beatriz Jimenez Polanco, Silvia Elena Yacarini Paredes, Raquel Assed Bezerra Segato
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Langerhans cell histiocytosis (LCH) is an inflammatory myeloid neoplasia commonly affecting children with frequent somatic mutations in MAPK pathway genes including BRAFV600E and MAP2K1. Some studies suggest that LCH cells can recruit and modulate in